In Vivo is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Big Data And The FDA: To Mine The Value, First Mind The Gaps

Executive Summary

INFORMED is a new initiative at the FDA to incubate new ideas in applying big data to boost the scientific, economic and social returns from the regulation of drugs and medical devices, with a particular focus on cancer.

Advertisement

Related Content

US FDA’s Khozin On Defining Big Data, Safety Signaling, And The Patient Experience in Cancer
'Watch This Space' Roche Execs Say, Outlining RWE Rationale For Flatiron Buy
RWE and Clinical Trials To Take Center Stage In UK Sector Deal Prospects
Real-World Evidence: Advice, Principles And Examples Emerge From FDA
US FDA Officials Provide Primer On 'Real-World' Data
Free And Open: The Next Wave In Clinical Trial Data?

Topics

Related Companies

Advertisement
UsernamePublicRestriction

Register

IV005339

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel